Mechanically robust 3D-printed microcapillary needles with anti-clogging capabilities
Ended Project Grant Awarded Last action
- Award ID
- R41GM153053
- Recipient
-
Seetrue Technology, LLC UEI LJ1ZKX7C8SL5
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $296,043
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from USAspending.gov.
Description
- Abstract
- Biomedical applications in both research and clinical settings rely on microinjection protocols that require using a hollow microcapillary needle to deliver foreign substances (e.g., nucleic acids, proteins, viruses, cells, and nanoparticles) directly into biological targets (e.g., cells, embryos, and tissues). This transgenic engineering technique has driven advances in fundamental research in areas including cell, systems, and developmental biology, stem cell gene manipulation, and human disease prevention modeling, as well as for medical applications including in vitro fertilization (IVF) cycle therapy, pre-implantation genetic diagnosis, and intraocular injection. However, the industry standard microneedles (ISNS) used for microinjection in research settings are typically produced lab-by-lab by physically "pulling" apart transparent glass capillary tubes, which results in needle variability. The inconsistencies can negatively affect experimental rigor, reproducibility, productivity, and microinjection efficacy. Thus, the ability to enhance and expand the capabilities of the microneedles that enable microinjection protocols could significantly impact diverse biomedical fields and applications. We hypothesize that by leveraging well-established "pyrolysis" post-processing strategies for enhancing the mechanical properties of DLW-printed 3D microstructures, we can achieve mechanically robust microinjection needles-based on our pending-patented MSP design-that simultaneously address all the pain points of ISNS. This proposal will systematically evaluate the utility of the mechanically robust 3D-printed microcapillary needles versus ISNS with regard to key quantitative metrics of performance underlying material delivery into zebrafish embryos by: 1) establishing and characterizing pyrolysis protocols for DLW-printed 3D microneedles, 2) interrogating the mechanical properties of pyrolyzed 3D microneedle prototypes in vitro, and 3) evaluating microinjection efficacy of pyrolyzed DLW-printed 3D microneedle prototypes versus ISNS using live zebrafish embryos in vivo. These innovative, geometrically sophisticated, functionally advantageous microneedle with robust mechanically properties hold unique promise to allow for fast, accurate, and consistent microinjections with minimal damage to injection targets (e.g., embryos).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $296,043 |
Quick answers
Who received award R41GM153053?
R41GM153053 was awarded to Seetrue Technology, LLC by National Institute of General Medical Sciences (National Institutes of Health) on April 18, 2024.
How much is award R41GM153053 worth?
$296,043 has been obligated on R41GM153053.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award